ASN
RARE icon

Advisory Services Network’s Ultragenyx Pharmaceutical RARE Stock Holding History

Advisory Services Network’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20
Closed -$602 – 3704
2025
Q3 		$602 Buy
+20
New +$600 ﹤0.01% 4019
2024
Q1 		– Sell
-1
Closed -$48 – 3165
2023
Q4 		$48 Buy
+1
New +$39 ﹤0.01% 3812
2023
Q2 		– Sell
-1
Closed -$40 – 3150
2023
Q1 		$40 Hold
1
– – ﹤0.01% 3932
2022
Q4 		$46 Buy
+1
New +$39 ﹤0.01% 3945
2021
Q1 		– Hold
0
– – – 2752
2020
Q4 		– Sell
-16
Closed -$1.9K – 3655
2020
Q3 		$1K Buy
+16
New +$1.33K ﹤0.01% 3382
2020
Q1 		– Sell
-25
Closed -$1K – 3248
2019
Q4 		$1K Buy
+25
New +$1.03K ﹤0.01% 2994

Other funds holding RARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return